Cover Image

Exploring the therapeutic potential of apabetalone in diabetic kidney disease: Bridging preclinical findings with clinical translation

Saved in:

Bibliographic Details
Main Authors:	Honglian Luo (Author), Yi Yao (Author), Wenhua Wang (Author), Wei Shen (Author), Guo Zhao (Author)
Format:	Book
Published:	Elsevier, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease
by: Ewelina Kulikowski, et al.
Published: (2018)

Bridging the gap between basic and applied biology: towards preclinical translation
by: Ross L. Cagan, et al.
Published: (2013)

The Potential of Renal Progenitor Cells in Kidney Diseases: Preclinical Findings
by: Jeong Hyun Jo, et al.
Published: (2019)

Role of Preclinical Arthritis Models for the Clinical Translation of Anti-Arthritic Therapeutics
by: L Ronibala Singha, et al.
Published: (2023)

Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease
by: Sylwia Wasiak, et al.
Published: (2020)

Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis
by: Min Wang, et al.
Published: (2024)

Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
by: Sultan Alshehri, et al.
Published: (2020)

Commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"
by: Kaiqing Li, et al.
Published: (2024)

The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
by: Elisabet Jerlhag
Published: (2023)

Preclinical MRI of the Kidney Methods and Protocols /
Published: (2021)

Preclinical MRI of the Kidney Methods and Protocols
Published: (2021)

Preclinical MRI of the Kidney Methods and Protocols
Published: (2021)

Correspondence: Reply to commentary on "Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis"
by: Min Wang, et al.
Published: (2024)

PBPK-based translation from preclinical species to humans for the full-size IgG therapeutic efalizumab
by: Maria Franz, et al.
Published: (2024)

Cutting Edge Preclinical Models in Translational Medicine
Published: (2020)

Modeling Parkinson's Disease: Bridging the Translational Gap
Published: (2019)

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)
by: Raffaella Willmann, et al.
Published: (2020)

Inhibition of epigenetic reader proteins by apabetalone counters inflammation in activated innate immune cells from Fabry disease patients receiving enzyme replacement therapy
by: Li Fu, et al.
Published: (2022)

Translation of preclinical ethnomedicine data in LMICs: the example of rooibos
by: Lesha Pretorius, et al.
Published: (2023)

The discovery of rivaroxaban: translating preclinical assessments into clinical practice
by: Dagmar eKubitza, et al.
Published: (2013)

Predictive Simulations in Preclinical Oncology to Guide the Translation of Biologics
by: Shujun Dong, et al.
Published: (2022)

Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies
by: Min Zhu, et al.
Published: (2022)

Kidney donation: bridging the gap in the shortage of kidney transplants in Malaysia
by: Farida Islahudin, et al.
Published: (2022)

Kidney Health for All: Bridging the Gap in Kidney Health Education and Literacy
by: Robyn G. Langham, et al.
Published: (2022)

BRIDGING THE GAP EXPLORING THE INTRICATE LINK BETWEEN PERIODONTAL DISEASE AND CHRONIC KIDNEY HEALTH. A NARRATIVE REVIEW
by: Irina-Georgeta Sufaru, et al.
Published: (2023)

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research
by: Amy S. Fisher, et al.
Published: (2021)

Preclinical research in Rett syndrome: setting the foundation for translational success
by: David M. Katz, et al.
Published: (2012)

Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success
by: Galina Dragneva, et al.
Published: (2013)

MG53: A potential therapeutic target for kidney disease
by: Ben Ke, et al.
Published: (2023)

Model for bridging the translational "valleys of death" in spinal cord injury research
by: Barrable B, et al.
Published: (2014)

Bridging the Translational Divide in Pain Research: Biological, Psychological and Social Considerations
by: Chulmin Cho, et al.
Published: (2021)

Building bridges with zebrafish: highlights of the 'Zebrafish Models in Translational Medicine' meeting
Published: (2013)

HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa
by: Christos C. Zouboulis, et al.
Published: (2023)

The potential application of natural products in cutaneous wound healing: A review of preclinical evidence
by: E Liu, et al.
Published: (2022)

Therapeutic potential of Erxian decoction and its special chemical markers in depression: a review of clinical and preclinical studies
by: Ning-Xi Zeng, et al.
Published: (2024)

Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations
by: Natalia L. Klyachko, et al.
Published: (2020)

Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer's Disease: Preclinical to Clinical Trial Insights
by: Kushagra Nagori, et al.
Published: (2023)

Therapeutic Potential of Controlled Delivery Systems in Asthma: Preclinical Development of Flavonoid-Based Treatments
by: Sergio M. Borghi, et al.
Published: (2022)

Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases
by: Radha Krishan Shandil, et al.
Published: (2022)

The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury
by: Juan Pang, et al.
Published: (2022)